Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1992 1
1996 1
2003 1
2004 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide.
Tarshish P, Bernstein J, Edelmann CM Jr. Tarshish P, et al. Pediatr Nephrol. 2004 Jan;19(1):51-6. doi: 10.1007/s00467-003-1315-x. Epub 2003 Nov 22. Pediatr Nephrol. 2004. PMID: 14634864 Clinical Trial.
Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children.
Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr. Tarshish P, et al. Pediatr Nephrol. 1992 Mar;6(2):123-30. doi: 10.1007/BF00866289. Pediatr Nephrol. 1992. PMID: 1571205 Clinical Trial.
Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.
[No authors listed] [No authors listed] J Pediatr. 1982 Oct;101(4):514-8. doi: 10.1016/s0022-3476(82)80692-6. J Pediatr. 1982. PMID: 7119952
Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.
Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Tarshish P, et al. Pediatr Nephrol. 1996 Oct;10(5):590-3. doi: 10.1007/s004670050167. Pediatr Nephrol. 1996. PMID: 8897562 Clinical Trial.
Feedback